Survival analysis of ovarian and endometrial cancer patients displaying different levels of Signature Score revealed that cases displaying high Signature Scores (top quartile) exhibited significantly worse survival compared to patients with low scores (bottom quartile), suggesting that high PAX8/MECOM activity identifies a subset of patients bearing particularly aggressive tumors. Here, PAX8 is linked to endometrial cancer.